Two new studies show certain patients with inflammatory bowel disease may have an increased risk of skin cancer, according to findings published in Gastroenterology and an American Gastroenterological Association news release.
In the first study, researchers found exposure to thiopurines, a commonly used class of immunosuppressants, significantly increased the risk of nonmelanoma skin cancer in patients with IBD. In a second study, researchers found certain individuals with IBD, such as men with Crohn's disease, may have an increased risk of basal cell carcinoma.
Related Articles about IBD:
Fecal Transplants Gaining Popularity
Researchers Develop Formula to Predict Post Surgery Complications in IBD Patients
NSAIDs May Increase Women's Risk of Crohn's Disease
In the first study, researchers found exposure to thiopurines, a commonly used class of immunosuppressants, significantly increased the risk of nonmelanoma skin cancer in patients with IBD. In a second study, researchers found certain individuals with IBD, such as men with Crohn's disease, may have an increased risk of basal cell carcinoma.
Related Articles about IBD:
Fecal Transplants Gaining Popularity
Researchers Develop Formula to Predict Post Surgery Complications in IBD Patients
NSAIDs May Increase Women's Risk of Crohn's Disease